Capillary electrophoresis studies on the aggregation process of β-amyloid 1-42 and 1-40 peptides
✍ Scribed by Stefania Sabella; Milena Quaglia; Cristina Lanni; Marco Racchi; Stefano Govoni; Gabriele Caccialanza; Alberto Calligaro; Vittorio Bellotti; Ersilia De Lorenzi
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 173 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0173-0835
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Alzheimers disease (AD) is the most frequent cause of late-life dementia, with pathological characteristics of extracellular aggregation of amyloid b-peptides (Abs) with 39 ± 43 amino acids, which are proteolytically derived from the transmembrane amyloid precursor protein (APP). [1] Recent studies
## Abstract It is generally postulated that amyloid‐β‐peptides play a central role in the progressive neurodegeneration observed in Alzheimer's disease. Important pathological properties of these peptides, such as neurotoxicity and resistance to proteolytic degradation, depend on the ability of amy
## Abstract The aggregation of full‐length (residues 1–40) amyloid β‐peptide (Aβ) and fragments corresponding to residues 1–23 and 24–40 was studied by electrospray mass spectrometry, using gramicidin as a non‐aggregating reference. Following a lag period, Aβ(1–40) at 140 µM concentration aggregate
## Abstract The modulation of CD44, VCAM‐1 and CD71 expression was analysed by flow cytometry in the 1321N1 astrocytoma cell line in the presence of interleukin‐1β (IL1β), tumour necrosis factor‐α (TNFα) and 1–40 or 25–35 β‐amyloid (Aβ) fragments. The percentage of 1321N1 astrocytoma cell line expr